Americann ACAN · USD

Its shares trade under the ticker ACAN. It has been listed since 10 September 2013. In the fiscal year to 30 September 2024, it reported revenue of $1.3m and a net loss of $1.3m. At that date it held total assets of $14.1m and shareholders' equity of $4.5m.

Americann, Inc. is engaged in the development of medical cannabis cultivation and processing properties. The company is headquartered in Denver, Colorado. The company went IPO on 2013-09-10. To support local businesses that seek to serve cannabis patients in their communities, the Company initiated the AmeriCann Preferred Partner Program. As of September 30, 2016, it had one Preferred Partner in Colorado, which was 4900 Jackson, LLC and one Preferred Partner in Massachusetts, which was Coastal Compassion, Inc. Through this program, the Company intends to provide a set of resources, including cultivation facilities, access to a team of experts and in certain cases, capital for its partner's businesses. The company focuses on leasing facilities to its Preferred Partners that will be designed with its cultivation and processing system called Cannopy. The Cannopy includes automation throughout the production life cycle, customized workflow processes, monitoring and controls.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Timothy KeoghChief Executive Officer, Director, since 2014$180,000
• Mr. Benjamin BartonChief Financial Officer, Chief Accounting Officer, Director, since 2014$180,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.